Suppr超能文献

Yars/dominant 中间型腓骨肌萎缩症和 Sptlc1/遗传性感觉运动神经病 1 型的精确小鼠模型。

Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.

机构信息

The Jackson Laboratory, Bar Harbor, Maine, USA.

Institute for Clinical Chemistry, University of Zurich, Zurich, Switzerland.

出版信息

J Anat. 2022 Nov;241(5):1169-1185. doi: 10.1111/joa.13605. Epub 2021 Dec 7.

Abstract

Animal models of neurodegenerative diseases such as inherited peripheral neuropathies sometimes accurately recreate the pathophysiology of the human disease, and sometimes accurately recreate the genetic perturbations found in patients. Ideally, models achieve both, but this is not always possible; nonetheless, such models are informative. Here we describe two animal models of inherited peripheral neuropathy: mice with a mutation in tyrosyl tRNA-synthetase, Yars , modeling dominant intermediate Charcot-Marie-Tooth disease type C (diCMTC), and mice with a mutation in serine palmitoyltransferase long chain 1, Sptlc1 , modeling hereditary sensory and autonomic neuropathy type 1 (HSAN1). Yars mice develop disease-relevant phenotypes including reduced motor performance and reduced nerve conduction velocities by 4 months of age. Peripheral motor axons are reduced in size, but there is no reduction in axon number and plasma neurofilament light chain levels are not increased. Unlike the dominant human mutations, the Yars mice only show these phenotypes as homozygotes, or as compound heterozygotes with a null allele, and no phenotype is observed in E196K or null heterozygotes. The Sptlc1 mice carry a knockin allele and show the anticipated increase in 1-deoxysphingolipids in circulation and in a variety of tissues. They also have mild behavioral defects consistent with HSAN1, but do not show neurophysiological defects or axon loss in peripheral nerves or in the epidermis of the hind paw or tail. Thus, despite the biochemical phenotype, the Sptlc1 mice do not show a strong neuropathy phenotype. Surprisingly, these mice were lethal as homozygotes, but the heterozygous genotype studied corresponds to the dominant genetics seen in humans. Thus, Yars homozygous mice have a relevant phenotype, but imprecisely reproduce the human genetics, whereas the Sptlc1 mice precisely reproduce the human genetics, but do not recreate the disease phenotype. Despite these shortcomings, both models are informative and will be useful for future research.

摘要

神经退行性疾病的动物模型,如遗传性周围神经病,有时能准确地再现人类疾病的病理生理学,有时能准确地再现患者中发现的遗传扰动。理想情况下,模型可以同时实现这两个目标,但这并不总是可能的;尽管如此,这些模型还是有启发性的。在这里,我们描述了两种遗传性周围神经病的动物模型:一种是酪氨酸 tRNA 合成酶(Yars)突变的小鼠,模拟显性中间型腓骨肌萎缩症(diCMTC),另一种是丝氨酸棕榈酰转移酶长链 1(Sptlc1)突变的小鼠,模拟遗传性感觉运动神经病 1 型(HSAN1)。Yars 小鼠在 4 个月大时就出现了与疾病相关的表型,包括运动性能下降和神经传导速度减慢。周围运动轴突的大小减小,但轴突数量没有减少,血浆神经丝轻链水平也没有增加。与显性人类突变不同,Yars 小鼠仅作为纯合子或与无效等位基因的复合杂合子表现出这些表型,而 E196K 或无效杂合子则没有表型。Sptlc1 小鼠携带一个敲入等位基因,表现出预期的循环和多种组织中 1-脱氧鞘氨醇的增加。它们也有与 HSAN1 一致的轻微行为缺陷,但在外周神经或后爪或尾巴的表皮中没有表现出神经生理缺陷或轴突丢失。因此,尽管有生化表型,但 Sptlc1 小鼠并没有表现出强烈的神经病表型。令人惊讶的是,这些小鼠作为纯合子是致命的,但研究中的杂合基因型与人类中看到的显性遗传学相对应。因此,Yars 纯合子小鼠具有相关的表型,但不能精确地再现人类遗传学,而 Sptlc1 小鼠精确地再现了人类遗传学,但不能再现疾病表型。尽管存在这些缺陷,但这两种模型都具有启发性,将有助于未来的研究。

相似文献

引用本文的文献

10
Sphingolipids in neurodegenerative diseases.神经退行性疾病中的鞘脂类
Front Neurosci. 2023 Feb 16;17:1137893. doi: 10.3389/fnins.2023.1137893. eCollection 2023.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验